Craig Lustig

Assoc Dir, Ruesch Ctr for the Cure of GI Cancers. Brain cancer survivor. Passionate about fixing healthcare, cancer, communication, advocacy.

[Anwaar Saeed @AnwaarSaeed3]

🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯
Years of grit & belief led us here 🥹
Endless thanks to Exelixis⁩ for the trust & Dr. Hecht for leading this global win with me! 🎉 ⁦@UPMCHillmanCC⁩ https://t.co/qLG56BiBmc

[Craig Lustig @clustinthewind]

Shocking but not surprising. Any Republicans going to condemn this violence? Tell Trump his statements incite violence?
I’m not holding my breath.
Live Updates: Minnesota Lawmaker Is Assassinated in Act of ‘Targeted Political Violence’ https://t.co/q1LGJiz1Pn via @NYTimes

[Cure GI Cancers @RueschCenter]

Claudine Isaacs, MD, FRCPC, FASCO of @LombardiCancer
was a discussant at this mornings LBA 1008 session at the #ASCO25 meeting.

[Cure GI Cancers @RueschCenter]

Join us to review exciting research from the #ASCO25 Annual Meeting. @marshalj23, @benweinbergmd, @mnoel3232, and @ReetuMukherjiMD will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: https://t.co/YOV4IJpMdS

[Stephen V Liu, MD @StephenVLiu]

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

[Pashtoon Kasi MD, MS @pashtoonkasi]

#ASCO25 1st practice changing presentation, which has already been our practice since the initial readout for our patients with #BRAFV600E mutant colorectal cancer.

More options for our patients.👏🏽

@OncoAlert

[Benjamin Weinberg, MD, FACP @benweinbergmd]

Thrilled to announce our new publication: "Rethinking the Rise of Early Onset GI Cancers" @JNCI_Now Spectrum

@RueschCenter @marshalj23 @priyanka_kanth @ReetuMukherjiMD @MarionHartley4 @annebchin @CancerMicrobes @BlaesAnneMD @NancyYouMD @GiannakisLab

https://t.co/Iu8cR9Nta1

[Cure GI Cancers @RueschCenter]

“This phenomenon among young people has sounded an alarm because it’s not going away,” says @marshalj23, director of the @RueschCenter at @LombardiCancer.

In the search to find out what’s driving these high cancer rates, researchers like Drs. Alexandrov and Marshall have been exploring how the gut microbiome may influence cancer development.
via @EverydayHealth
https://t.co/KV0WBZfSGs

[Cure GI Cancers @RueschCenter]

It’s a beautiful day for the 8th Annual Ruesch Center Classic golf tournament. This event provides vital support for GI cancer research at @LombardiCancer. We are grateful for our sponsors and players' continued commitment to the Ruesch Center's work.

[Cure GI Cancers @RueschCenter]

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty at @LombardiCancer and @MedStarGUH wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay

[Benjamin Weinberg, MD, FACP @benweinbergmd]

Paper is out!!! FDA approved for NRG1 Fusion+ Non-Small Cell #LungCancer and #PancreaticCancer

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

https://t.co/LCPM14lBaF

@AliSchram @StephenVLiu @GIcancerDoc @KReissMD @MerusNV @NEJM @MSKCancerCenter @LombardiCancer

[Cure GI Cancers @RueschCenter]

“Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal​ cancers with microscopic residual disease.”

Research by @ReetuMukherjiMD, Hongkun Wang, @RuthHe12, @mnoel3232, @benweinbergmd, Louis Weiner and @marshalj23 @LombardiCancer @ASCO #GI25.

Abstract # TPS850 Board L3

[Cure GI Cancers @RueschCenter]

Today, during @CCAlliance #allycon 2024, Project Cure CRC Co-Chairs, @skopetz, @marshalj23, #KatieChudnovsky, @coloncancermike, and #ChristopherLieuMD gathered. Learn more about the work of this incredible CRC research initiative. https://t.co/9TlSY6DOUy

[Tim Walz @Tim_Walz]

The coach in me knows we can win big this November if we work as a team.

[John Marshall @marshalj23]

Nothing happens without the great Ruesch team!

[Cure GI Cancers @RueschCenter]

We look forward to reconnecting with our colleagues from around the world and disseminating exciting research at #ASCO24. Be sure to join us at booth #11015 to see @marshalj23, @RuthHe12, @benweinbergmd, @mnoel3232, and @ReetuMukherjiMD.

[Cure GI Cancers @RueschCenter]

Today, on #ClinicalTrialsDay, we recognize the contributions of clinical research professionals in advancing research at @LombardiCancer. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for cancer treatment clinical trials.

[Cure GI Cancers @RueschCenter]

Today @marshalj23 joined physicians, researchers, patients, survivors, caregivers, and legislators on the hill, to discuss stomach cancer and advocate for those impacted by this disease.

[Cure GI Cancers @RueschCenter]

Save the Date for the 15th Annual Ruesch Center Symposium- Nov 22-23, 2024! Sign up to receive more information about the agenda and speakers. https://t.co/LzWYtzoZ8O @LombardiCancer @OncLive

[PhRMA @PhRMA]

ICYMI: PhRMA’s @ScottLaGanga recently received the 2024 Margaret L. Hodges Leadership Award from @LombardiCancer for his leadership in founding the Ruesch Center Golf Tournament, which has raised $1.5 million for gastrointestinal cancer research. https://t.co/e218o6o8eR